加强欧洲镇痛、镇静与谵妄管理:一项跨国、前瞻性、干预性前后对照试验
该研究为前瞻性、跨国、干预性前后对照试验,纳入德国、奥地利、瑞士和英国10个中心的12个ICU,共430例患者。ICU接受为期6周的结构化教育项目(在线讲座、教学视频、教育讲义和床旁教学),在干预前(T1)、干预后6周(T2)和干预后1年(T3)进行三次1日点患病率评估。结果显示,接受全部三项PAD评估的患者比例从T1的55%变为T2的53%,T3升至73%(p=0.003);谵妄筛查率、疼痛评估率和非药物谵妄预防措施比例在T3均显著提高,镇静评估率无显著变化。多因素回归显示,与T1相比,T3时患者更可能接受谵妄评估、镇静评估或全部三项PAD评估。
要点
- 接受全部三项PAD评估的患者比例从T1的55%(107/195)变为T2的53%(68/129),T3升至73%(77/106)(p=0.003)。
- 谵妄筛查率从T1的64%(124/195)升至T2的65%(84/129)和T3的77%(82/106)(p=0.041)。
- 疼痛评估率从T1的87%(170/195)升至T2的92%(119/129)和T3的98%(104/106)(p=0.005)。
- 接受非药物谵妄预防措施的患者比例从T1的58%(114/195)升至T2的80%(103/129)和T3的91%(96/106)(p<0.001)。
- 多因素回归显示,与T1相比,T3时患者更可能接受谵妄评估(OR 2.138,95%CI 1.206-3.790;p=0.009)、镇静评估(OR 4.131,95%CI 1.372-12.438;p=0.012)或全部三项PAD评估(OR 2.295,95%CI 1.349-3.903;p=0.002)。
适用人群与场景
- 来自德国、奥地利、瑞士和英国10个中心的12个ICU的成人患者(共430例)。
处置流程与药物剂量
- ICU接受为期6周的结构化教育项目,包括在线讲座、教学视频、教育讲义和床旁教学。
研究设计与关键结果
- 研究类型:前瞻性、跨国、干预性前后对照试验;样本量430例;10个中心12个ICU;在干预前(T1)、干预后6周(T2)和干预后1年(T3)进行三次1日点患病率评估。
- 接受全部三项PAD评估的患者比例:T1 55%(107/195),T2 53%(68/129),T3 73%(77/106)(p=0.003)。
- 谵妄筛查率:T1 64%(124/195),T2 65%(84/129),T3 77%(82/106)(p=0.041)。
- 疼痛评估率:T1 87%(170/195),T2 92%(119/129),T3 98%(104/106)(p=0.005)。
- 镇静评估率无显著变化。
- 非药物谵妄预防措施比例:T1 58%(114/195),T2 80%(103/129),T3 91%(96/106)(p<0.001)。
- 多因素回归:与T1相比,T3时患者更可能接受谵妄评估(OR 2.138,95%CI 1.206-3.790;p=0.009)、镇静评估(OR 4.131,95%CI 1.372-12.438;p=0.012)或全部三项PAD评估(OR 2.295,95%CI 1.349-3.903;p=0.002)。
证据类型、等级与局限
- 证据类型:前瞻性、跨国、干预性前后对照试验;临床试验注册号ClinicalTrials.gov: NCT03553719。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在常规诊疗中,许多患者未接受PAD评估;结构化教育干预后1年评估率显著提高,提示该干预可能改善长期评估实践。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The objective of this study was to analyze the impact of a structured educational intervention on the implementation of guideline-recommended pain, agitation, and delirium (PAD) assessment.
METHODS: This was a prospective, multinational, interventional before-after trial conducted at 12 intensive care units from 10 centers in Germany, Austria, Switzerland, and the UK. Intensive care units underwent a 6-week structured educational program, comprising online lectures, instructional videos, educational handouts, and bedside teaching. Patient-level PAD assessment data were collected in three 1-day point-prevalence assessments before (T1), 6 weeks after (T2), and 1 year after (T3) the educational program.
RESULTS: A total of 430 patients were included. The rate of patients who received all three PAD assessments changed from 55% (107/195) at T1 to 53% (68/129) at T2, but increased to 73% (77/106) at T3 (p = 0.003). The delirium screening rate increased from 64% (124/195) at T1 to 65% (84/129) at T2 and 77% (82/106) at T3 (p = 0.041). The pain assessment rate increased from 87% (170/195) at T1 to 92% (119/129) at T2 and 98% (104/106) at T3 (p = 0.005). The rate of sedation assessment showed no signficiant change. The proportion of patients who received nonpharmacological delirium prevention measures increased from 58% (114/195) at T1 to 80% (103/129) at T2 and 91% (96/106) at T3 (p < 0.001). Multivariable regression revealed that at T3, patients were more likely to receive a delirium assessment (odds ratio [OR] 2.138, 95% confidence interval [CI] 1.206-3.790; p = 0.009), sedation assessment (OR 4.131, 95% CI 1.372-12.438; p = 0.012), or all three PAD assessments (OR 2.295, 95% CI 1.349-3.903; p = 0.002) compared with T1.
CONCLUSIONS: In routine care, many patients were not assessed for PAD. Assessment rates increased significantly 1 year after the intervention. Clinical trial registration ClinicalTrials.gov: NCT03553719.
参考来源
- Paul N, Grunow JJ, Rosenthal M, et al. Enhancing European Management of Analgesia, Sedation, and Delirium: A Multinational, Prospective, Interventional Before-After Trial. Neurocrit Care. 2023. PMID: 37697129. doi:10.1007/s12028-023-01837-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。